FDA Investigator Ruben C Ayala, PharmD
Ruben C Ayala, PharmD has conducted inspections on 24 sites in 8 countries as of 23 Oct 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
24
Last Inspection Date:
23 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
India,
United States of America,
Italy,
Israel,
Jordan,
United Kingdom of Great Britain and Northern Ireland,
Mexico,
Colombia
FDA Investigators that have inspected at least one site in common with Ruben C Ayala, PharmD:
Alan A Rivera,
Alan P Kurtzberg,
Alanna L Mussawwir Bias,
Alexander M Kay,
Allen F Hall,
Amanda E Lewin, PhD,
Anthony E Keller, RPh,
Anthony N Onianwa,
Arindam Dasgupta, PhD,
Azza Talaat,
Barbara A Rusin,
Barbara I Rogolsky,
Barbara M Frazier,
Bonita S Chester,
Bruce H Mccullough,
Camille D Brown,
Carl A Huffman, III,
Carl J Montgomery,
Carmen Y Fisher,
Chilton L Ng,
Courtney N Long,
Craig A Garmendia,
Dandan Wang, PhD,
Daniel L Aisen,
David R Heiar,
Dawn C Olenjack,
Douglas A Campbell,
Dr. Gopa Biswas, PhD,
Dr. Sriram Subramaniam, PhD,
Eric M Mueller, PharmD,
Farhana Khan,
Felix Maldonado,
Gajendiran Mahadevan, PhD,
Gene R Gunn,
Geoffrey K Kilili,
Gretchen Lf Trendel,
Gulshan R Anand,
Hasan A Irier, PhD,
Hector Jcolon Torres,
Humberto Z Gomez,
Hyojong Kwon, PhD,
Iraida Ortiz,
Ivis L Negron,
James R Fleckenstein,
Janet B Abt,
Janete F Guardia,
Jeanne J Thai,
Jennifer C Adams,
Joanne M Schlossin,
Joel D Martinez,
Jogy George,
John A Kadavil, PhD,
John S Hartford,
Jonathan R Campos,
Joseph L Despins, PhD,
Julie N Vosilus,
Kara A Scheibner, PhD,
Kathryn A Krentz,
Kellia N Hicks,
Kenneth M Gordon,
Kevin A Gonzalez,
Kimberly A Dux,
Kip J Hanks,
Kirtida Patel,
Lakecha N Lewis,
Larry K Austin,
Li Hongpaul Yeh, PhD,
Linda R Kuchenthal,
Lori A Gioia,
Makini Cobourne Duval, PhD,
Marc R Dickens,
Marcus F Yambot,
Margaret M Annes,
Marian E Ramirez,
Mark W Babbitt,
Matthew C Watson,
Matthew J Gretkierewicz,
Meisha R Sampson,
Meisha Waters,
Michael A Charles,
Michael S Araneta,
Michele L Glendenning,
Michele L Obert,
Michele Perry Williams,
Mohsen Rajabi Abhari, FDA,
Mra Mcculloughj,
Nancy A Bellamy,
Nicola M Fenty Stewart,
Nicole M Bell,
Noreen Muñiz,
Paula J Bretz,
Perry H Gambrell,
Peter R Lenahan,
Raymond T Oji,
Rebecca Rodriguez,
Rebecca T Davis,
Regina T Brown,
Richard H Penta,
Rita K Kabaso,
Robert J Doyle,
Rochelle K Kimmel,
Roger F Zabinski,
Ronda Rloyd Jones,
Sam H Haidar, PhD,
Sandra A Hughes,
Sandra S Saniga,
Satheesh Thomas,
Scott B Laufenberg,
Sean R Marcsisin,
Sherri N Rohlf, MD,
Shirley H Isbill,
Sri Ramakrishnaiah Yellela, PhD,
Sripal R Mada, PhD,
Stephen D Brown,
Steven M Weinman,
Stuart W Russell,
Sunitha K Rajaram, PhD,
Susanne M Richardson, MS RAC,
Tawny L Colling,
Thea C Grome,
Thomas J Arista,
Thomas W Gordon,
Tiffani D Wilson,
Timothy C Grome,
Torrance J Slayton,
Tracey L Harris,
Uttaniti Limchumroon (Tom),
Vickie J Kanion,
Viviana Matta,
Wayne D Mcgrath,
Wayne T Smith,
William J Leonard,
Wr Bowman,
Xiaohan Cai, PhD,
Xikui Chen (nmi), PhD,
Yiyue Zhang (nmi), PhD,
Young M Choi, PhD,
Yumi J Hiramine,
Zachary L Miller,
Zerita White
Ruben C Ayala, PharmD's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2014 | FDA 483 | Integris Bioservices LLC - Form 483, 2014-08-29 |
June, 2016 | FDA 483 | Integris Bioservices LLC - Form 483, 2016-06-24 |
April, 2015 | FDA 483 | Synchron Research Services Private Limited - Form 483, 2015-04-03 |
November, 2013 | FDA 483 | Sun Pharmaceutical Industries Limited - Form 483, 2013-11-22 |
June, 2016 | EIR | Integris Bioservices LLC - EIR, 2016-06-24 |
November, 2016 | FDA 483 | International Pharmaceutical Research Center - Form 483, 2016-11-03 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more